Bristol Myers's most recent trend suggests a bullish bias. One trading opportunity on Bristol Myers is a Bull Put Spread using a strike $53.50 short put and a strike $48.50 long put offers a potential 20.19% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $53.50 by expiration. The full premium credit of $0.84 would be kept by the premium seller. The risk of $4.16 would be incurred if the stock dropped below the $48.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Bristol Myers is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Bristol Myers is bullish.
The RSI indicator is at 79.57 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Bristol Myers
Will Teva (TEVA) Beat Q3 Earnings on Strong Generic Sales?
Wed, 29 Oct 2014 20:20:01 GMT
Insider Trading Alert – BLUE, CHRW And BMY Traded By Insiders
Wed, 29 Oct 2014 14:06:00 GMT
Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy
Tue, 28 Oct 2014 11:38:26 GMT
noodls – “We are thrilled that a company with the oncology experience and expertise of Bristol-Myers Squibb will be advancing our first clinical asset with the potential to provide a significant improvement …
Also on Market Tamer…
Follow Us on Facebook